NCT00019500View on ClinicalTrials.gov

Raloxifene in Preventing Breast Cancer in Premenopausal Women

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1998

Study Completion Date

June 30, 2005

Conditions
Breast Cancer
Interventions
DRUG

raloxifene

PROCEDURE

evaluation of cancer risk factors

Trial Locations (1)

20892

Medicine Branch, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00019500 - Raloxifene in Preventing Breast Cancer in Premenopausal Women | Biotech Hunter | Biotech Hunter